Alan M Ezrin

Title: Innovations and Contributions of Alan M Ezrin

Introduction

Alan M Ezrin is a notable inventor based in Miami, Florida, recognized for his significant contributions to the field of biomedical research. With a total of 14 patents to his name, he has made strides in understanding and addressing critical health issues.

Latest Patents

Among his latest patents, one focuses on the use of Tenascin-C as an extracellular marker of tumor-derived microparticles. This patent provides methods for isolating tumor-derived microparticles from a subject for analysis, specifically by isolating Tenascin-C positive microparticles from a sample. It also includes methods for determining the expression status of biomarkers in these microparticles and additional characteristics of the tumor-derived microparticles. Another significant patent relates to the detection of microparticle-associated proteins associated with spontaneous preterm birth. This disclosure provides methods for determining whether a pregnant woman is at an increased risk for premature delivery and offers strategies for decreasing that risk.

Career Highlights

Throughout his career, Alan has worked with various companies, including Cardiome Pharma Corp. and Pioma, Inc. His work in these organizations has contributed to advancements in medical technology and research.

Collaborations

Alan has collaborated with notable professionals in his field, including Gregory N Beatch and David Fedida. These collaborations have further enhanced his research and innovation efforts.

Conclusion

Alan M Ezrin's work exemplifies the impact of innovation in the biomedical field. His patents and collaborations reflect a commitment to improving health outcomes through scientific research and development.